NCT01398670View on ClinicalTrials.gov

Immunogenicity Study of Wockhardt's Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 Diabetics

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 29, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

May 31, 2013

Conditions
Type I Diabetes
Interventions
BIOLOGICAL

Insulin Lispro

"a. Lispro and Lispro Mix® 75/25 / Lispro Mix 50/50~The drugs would be administered subcutaneously"

BIOLOGICAL

Insulin Lispro

"Humalog® and Humalog® Mix75/25 /Humalog® Mix 50/50~The drugs would be administered subcutaneously"

Sponsors

Lead Sponsor

Wockhardt
All Listed Sponsors
lead

Wockhardt

INDUSTRY